by clicking the arrows at the side of the page, or by using the toolbar.
by clicking anywhere on the page.
by dragging the page around when zoomed in.
by clicking anywhere on the page when zoomed in.
web sites or send emails by clicking on hyperlinks.
Email this page to a friend
Search this issue
Index - jump to page or section
Archive - view past issues
Australian Journal of Pharmacy : February 2005
Now there’s new hope in the fight against Age-Related Macular Degeneration and its associated vision loss... “AMD is the leading cause of blindness and nearly two out of three Australians who live into their nineties will develop macular degeneration whilst nearly one person in four will eventually lose vision from it”1 • AREDS was the first major prospective study to show the value of high-potency vitamin and mineral supplements in preserving vision among certain people.2 • Bausch & Lomb Ocuvite® PreserVision®, a new high- potency antioxidant (Beta-carotene, vitamin C and E) and zinc combination, shown to be effective in the 10-year National Eye Institute Age-Related Eye Study (AREDS), is now available in Australia through pharmacy and optical outlets. Referencs: 1. Clear Insight report: The economic impact and cost of vision loss in Australia. August 2004. Eye Research Australia 2. AREDS Report No. 8 (Age-Related Eye Disease Study Research Group), 2001 (I): A Randomized, Placebo-Controlled, Clinical Trial of High-Dose Supplementation With Vitamins C and E, Beta Carotene, and Zinc for Age-Related Macular Degeneration and Vision Loss. Arch Ophthalmol.2001;119:1417-1436 Customer Service Australia: Tel 1800 251 150 Fax 1800 805 700 Email: Preservision@bausch.com • www.preservision.com.au Bausch & Lomb (Australia) Pty Ltd. ABN 34 000 650 251. Level 4, 113 Wicks Road, North Ryde, NSW 2113.